Education and Implementation of the DEA Required MATE curriculum into your practice

REGISTRATION REQUIRED: (Walk-ins without registration pending seat availability)

Flagler Hospital Providers (free):

Non-Flagler Hospital Provider ($249 per date; both dates $400, payable by check at door with registration):

Saturday, June 3, 2023 (Part 1) & Saturday, June 24, 2023 (Part 2)

Check In: 8am-9am| Conference 9am-1pm

Faculty: Jeremy Mirabile, MD, ABPM-ADM, FASAM Flagler Hospital, 400 Health Park Blvd., St. Augustine, FL 32084|Osceola/Matanzas/Alicia Rooms


According to Substance Abuse and Mental Health Services Administration (SAMHSA) the purpose of the Medication Access and Training Expansion (MATE) Act is to enable DEA-registered practitioners to “screen more widely for substance use disorders, treat pain appropriately, prevent substance misuse, and engage people in life-saving interventions”. The purpose of this CME activity is to provide medical practitioners with the necessary skills to evaluate and care for patients with addictive illness, including patients with concurrent pain and mental health issues.


For the education of DEA-registered providers (MD, DO, DDS, DMD, DPM, PA, and APRN).


June 3, 2023 - Part I

At the conclusion of this presentation, participants will be able to:

1. Describe the medical basis of Addiction Disease also referred to as Substance Use Disorders (SUD) including etiology and pathophysiology.

2. Discuss how to use validated screening tools for SUD to facilitate comprehensive SUD evaluations.

3. Explain ASAM Levels of care for the treatment of SUDs.

4. Initiate and manage FDA-approved medications for SUD.

5. Apply presented screening tools and practice guides into medical practice.

June 24, 2023 - Part II

At the conclusion of this presentation, participants will be able to:

1. Describe co-occurring mental disorders in the setting of substance abuse disorders (SUD) and concurrent medical illnesses with SUDs.

2. Explain emerging threats in opioids and the importance of educating a patient and their family on overdose prevention.

3. Discuss best practices regarding managing patient’s pain with co-occurring substance use disorders.

4. Recognize the importance of communication between medical specialties and using Prescription Drug Monitoring Programs (PDMPs), such as Florida’s EFORCSE®.

5. Implement the utilization of presented specific addiction medicine documentation required to treat and manage patients with substance use disorders.


Commercial Support: None Faculty: No relevant financial disclosures| CME Committee of Flagler Hospital: No relevant financial interest| No Investigational products/products not labeled for use.


Flagler Hospital is accredited by the Florida Medical Association to provide continuing medical education for physicians.

Flagler Hospital designates this educational activity for a maximum of 4.00 AMA PRA Category 1 Credit(s)TM per date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Flagler Hospital is accredited for Florida Board of Dentistry, Florida Board of Nursing, FL Board of Podiatric Medicine 50-664 for continuing education units.